Physician profile
Ronald Ray Magee
NPI 1013918317
$6,065.74
in general payments reported to CMS, 2019-2025
25 companies · $851 in 2025
The $851 reported for 2025 was less than what a typical Vascular Surgery provider received nationally (typical 2025 total: $927).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $233 · 2020: $1,181 · 2021: $1,220 · 2022: $81.82 · 2023: $1,562 · 2024: $936 · 2025: $851.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,758 · Travel and Lodging: $592.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,757.59 |
| Travel and Lodging | $591.89 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Endologix LLC | $2,211.63 | 2020-2025 | Afx2 Bifurcated Endograft System |
| Silk Road Medical, INC. | $1,458.71 | 2020-2024 | Enroute Transcarotid Neuroprotection System, Enroute Transcarotid Stent, Enroute Enflate Transcarotid Rx Balloon Dilatation Catheter |
| Surmodics, INC. | $574.30 | 2021-2025 | Pounce Thrombectomy, Pounce Venous Thrombectomy System, Pounce Thrombectomy System |
| Shockwave Medical, INC | $354.06 | 2023-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| W. L. Gore & Associates, INC. | $333.37 | 2021-2025 | Gore Tag Conformable Thoracic Endoprosthesis, Gore Excluder Thoracoabdominal Branch Endoprosthesis |
| Janssen Pharmaceuticals, INC | $304.17 | 2019-2024 | Xarelto |
| Acera Surgical, INC. | $154.38 | 2023-2025 | Restrata Wound Matrix |
| Organogenesis INC. | $119.21 | 2019-2020 | |
| Pfizer INC. | $72.19 | 2024-2025 | |
| Novartis Pharmaceuticals Corporation | $57.60 | 2024-2025 | |
| Merck Sharp & Dohme LLC | $57.37 | 2022-2023 | Verquvo |
| E.R. Squibb & Sons, L.L.C. | $55.18 | 2023-2025 | Camzyos, Eliquis |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $47.80 | 2024-2025 | Lifevest |
| Philips North America LLC | $44.44 | 2024 | (Ck4) Mcot |
| Amgen INC. | $36.42 | 2023 | Repatha |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Daiichi Sankyo INC. | $26.66 | 2023 | Injectafer |
| Innovation Technologies INC | $24.94 | 2023 | Irrisept |
| Acell, INC. | $22.63 | 2019 | |
| Cook Medical LLC | $21.24 | 2023 | Tornado |
| Kci USA, INC. | $18.44 | 2019 | |
| Boston Scientific Corporation | $17.41 | 2025 | Enroute Transcarotid Neuroprotection System |
| Astrazeneca Pharmaceuticals LP | $14.55 | 2019 | |
| Inari Medical, INC. | $14.33 | 2021 | |
| Lemaitre Vascular, INC. | $13.64 | 2023 | Artegraft Vascular Graft |
| Getinge USA Sales, LLC | $11.07 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ronald Magee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.